| NULL |
Ig heavy chain V-III region WEA |
SOS1 |
SOS1: Son of sevenless homolog 1 |
0.675 |
Evidence |
|
| NULL |
Ig lambda chain V-II region NEI |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
0.675 |
Evidence |
|
| RP2 |
RP2: Protein XRP2 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
0.675 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
GRB10 |
IPI00012752 |
0.675 |
Evidence |
|
| WASPIP |
IPI00552369 |
HLA-DQB1 |
HLA-DQB1: HLA class II histocompatibility antigen, DQB1*0602 beta chain precurso |
0.675 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
BCR |
BCR, BCR1, D22S11: Breakpoint cluster region protein |
0.675 |
Evidence |
|
| PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
AFAP |
AFAP1, AFAP: Actin filament-associated protein 1 |
0.675 |
Evidence |
|
| PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
USP21 |
USP21, USP23: Ubiquitin carboxyl-terminal hydrolase 21 |
0.675 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
0.675 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
0.675 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
0.675 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
0.675 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
0.672 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.672 |
Evidence |
|
| BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
BCAP31 |
BCAP31, BAP31, DXS1357E: B-cell receptor-associated protein 31 |
0.672 |
Evidence |
|
| IRF3 |
IRF3: Interferon regulatory factor 3 |
TAOK1 |
TAOK1, KIAA1361, MAP3K16: Serine/threonine-protein kinase TAO1 |
0.672 |
Evidence |
|
| EIF4EBP1 |
EIF4EBP1: Eukaryotic translation initiation factor 4E-binding protein 1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.672 |
Evidence |
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
CHUK |
IPI00556043 |
0.672 |
Evidence |
|
| E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
0.672 |
Evidence |
|
| ARPC4 |
ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
0.672 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
ARPC4 |
ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 |
0.672 |
Evidence |
|
| SILV |
SILV, D12S53E, PMEL17: Melanocyte protein Pmel 17 precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.672 |
Evidence |
|
| CTGF |
CTGF, CCN2, HCS24: Connective tissue growth factor precursor |
DAG1 |
DAG1: Dystroglycan precursor |
0.672 |
Evidence |
|
| GJA1 |
GJA1, GJAL: Gap junction alpha-1 protein |
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
0.672 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
0.672 |
Evidence |
|
- 
- 
-